Browsing by Author "Zhao, Ying"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Comparisons of diabetic retinopathy events associated with glucose‐lowering drugs in patients with type 2 diabetes mellitus: A network meta‐analysis
    (Wiley, 2018) Tang, Huilin; Li, Guangyao; Zhao, Ying; Wang, Fei; Gower, Emily W.; Shi, Luwen; Wang, Tiansheng; Epidemiology, School of Public Health
    Aim To assess the comparative effects of glucose‐lowering drugs (GLDs) on the risk of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM). Methods We systematically searched Cochrane Central Register of Controlled Trials, PUBMED and EMBASE from inception to January 17, 2017 to identify randomized controlled trials (RCTs) that reported DR events among T2DM patients receiving any GLD. Random‐effects pairwise and network meta‐analyses were performed to calculate odds ratios (ORs) with 95% confidence intervals (CIs). Results A total of 37 independent RCTs with 1806 DR events among 100 928 patients with T2DM were included. The mean duration of diabetes was 8.7 years and mean baseline HbA1c was 8.2% (SD, 0.5%). Our network meta‐analysis found that DPP‐4i (OR, 1.20; 95% CI, 0.87‐1.65), GLP‐1RA (OR, 1.19; 95% CI, 0.94‐1.52) and SGLT2 inhibitors (OR, 0.79; 95% CI, 0.49‐1.28) were not associated with a higher risk of DR than placebo; however, a significantly increased risk of DR was associated with DPP‐4i in the pairwise meta‐analysis (OR, 1.27; 95% CI, 1.05‐1.53). Sulfonylureas, on the other hand, were associated with a significantly increased risk of DR compared to placebo (OR, 1.67; 95% CI, 1.01‐2.76). Conclusions Current evidence indicates that the association between DPP‐4i, GLP‐1RA or SGLT2 inhibitors and risk of DR remains uncertain in patients with T2DM. Some evidence suggests that sulfonylureas may be associated with increased risk of DR. However, given that DR events were not systematically assessed, these effects should be explored further in large‐scale, well‐designed studies.
  • Thumbnail Image
    Item
    Dissolved carbon and CDOM in lake ice and underlying waters along a salinity gradient in shallow lakes of Northeast China
    (Elsevier, 2019) Song, Kaishan; Wen, Zhidan; Jacinthe, Pierre-André; Zhao, Ying; Du, Jia; Earth Sciences, School of Science
    The variations of DOC and DIC concentrations in lake ice and underlying waters were examined in 40 shallow lakes across the Songnen Plain, Northeast China. The lakes, frozen annually during winter, included freshwater and brackish systems (EC > 1000 μS cm−1; range: 171–12607 μS cm−1 in underlying water). Results showed that lake ice contained lower DOC (7.2 mg L−1) and DIC (6.7 mg L−1) concentration compared to the underlying waters (58.2 and 142.4 mg L−1, respectively). Large differences in DOC and DIC concentrations of underlying waters were also observed between freshwater (mean ± SD: 22.3 ± 11.5 mg L−1, 50.7 ± 20.6 mg L−1) and brackish lakes (83.3 ± 138.0 mg L−1, 247.0 ± 410.5 mg L−1). A mass balance model was developed to describe the relative distribution of solutes and chemical attributes between ice and the underlying waters. Results showed that water depth and ice thickness were the key factors regulating the spatial distribution of solutes in the frozen lakes. Chromophoric dissolved organic matter (CDOM) absorption coefficient at 320 nm, aCDOM(320) and specific UV absorbance (SUVA254) were used to characterize CDOM composition and quality. Compared to the underlying waters, CDOM present in ice largely included low aromaticity organic substances, an outcome perhaps facilitated by ice formation and photo-degradation. In ice and underlying freshwaters, CDOM predominantly included organic C fractions of high aromaticity, while low aromaticity organic substances were observed for brackish lakes. Results of this study suggest that, if water salinity increases due to climate change and anthropogenic activities, significant changes can occur in the dissolved carbon and fate of CDOM in these shallow lakes.
  • Thumbnail Image
    Item
    Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database
    (Springer, 2018-10) Zhao, Ying; Sun, Shusen; Li, Xiaotong; Ma, Xiang; Tang, Huilin; Sun, Lulu; Zhai, Suodi; Wang, Tiansheng; Epidemiology, School of Public Health
    Background Few studies on the causes of drug-induced anaphylaxis (DIA) in the hospital setting are available. Objective We aimed to use the Beijing Pharmacovigilance Database (BPD) to identify the causes of DIA in Beijing, China. Setting Anaphylactic case reports from the BPD provided by the Beijing Center for Adverse Drug Reaction Monitoring. Method DIA cases collected by the BPD from January 2004 to December 2014 were adjudicated. Cases were analyzed for demographics, causative drugs and route of administration, and clinical signs and outcomes. Main outcome measure Drugs implicated in DIAs were identified and the signs and symptoms of the DIA cases were analyzed. Results A total of 1189 DIA cases were analyzed. The mean age was 47.6 years, and 732 (61.6%) were aged from 18 to 59 years. A total of 627 patients (52.7%) were females. There was a predominance of cardiovascular (83.8%) followed by respiratory (55.4%), central nervous (50.1%), mucocutaneous (47.4%), and gastrointestinal symptoms (31.3%). A total of 249 different drugs were involved. DIAs were mainly caused by antibiotics (39.3%), traditional Chinese medicines (TCM) (11.9%), radiocontrast agents (11.9%), and antineoplastic agents (10.3%). Cephalosporins accounted for majority (34.5%) of antibiotic-induced anaphylaxis, followed by fluoroquinolones (29.6%), beta-lactam/beta-lactamase inhibitors (15.4%) and penicillins (7.9%). Blood products and biological agents (3.1%), and plasma substitutes (2.1%) were also important contributors to DIAs. Conclusion A variety of drug classes were implicated in DIAs. Patients should be closely monitored for signs and symptoms of anaphylaxis when medications are administered especially with antibiotics, TCM, radiocontrast and antineoplastic agents.